Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.06 USD | +7.29% | +12.57% | +14.76% |
May. 14 | Eterna Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Eterna Therapeutics Inc. Appoints Mahendra Rao to Its Scientific Advisory Board | CI |
Business Summary
Number of employees: 8
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cytokine-based Therapy
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sanjeev Luther
CEO | Chief Executive Officer | 62 | Dec. 31 |
Sandra Gurrola
DFI | Director of Finance/CFO | 57 | 21-06-20 |
Megan Yung
LAW | General Counsel | - | 23-05-23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
James Bristol
CHM | Chairman | 77 | 23-10-29 |
William Wexler
BRD | Director/Board Member | 65 | 22-06-06 |
Dorothy Clarke
BRD | Director/Board Member | 59 | 23-08-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 5,410,331 | 3,283,683 ( 60.69 %) | 0 | 60.69 % |
Stock B | 0 | 156,000 | 0 | 0 |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+14.76% | 10.39M | |
+57.10% | 59.34B | |
+43.17% | 40.24B | |
-5.06% | 39.88B | |
-5.56% | 28.55B | |
+14.65% | 27.26B | |
-21.55% | 19.23B | |
+31.74% | 12.61B | |
+2.02% | 12.49B | |
+25.37% | 12.28B |
- Stock Market
- Equities
- ERNA Stock
- Company Eterna Therapeutics Inc.